Key Facts Surrounding This News Item
- KOD had returned 0.00% year-to-date leading up to today’s news, versus a +10.75% return from the benchmark S&P 500 during the same period.
More Info About Kodiak Sciences Inc (KOD)
Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York. View our full KOD ticker page with ratings, news, and more.